Cargando…
Practical management of new oral anticoagulants after total hip or total knee arthroplasty
Within the past 5 years, the oral anticoagulants rivaroxaban, apixaban, and dabigatran etexilate have been approved for the prevention of venous thromboembolism in adult patients after elective hip or knee arthroplasty in the European Union and many other countries worldwide. These agents differ fro...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838782/ https://www.ncbi.nlm.nih.gov/pubmed/24249360 http://dx.doi.org/10.1007/s12306-013-0306-8 |